Related Links
ARALAST NP Therapy
Choose a therapy that offers support for your patients.
ARALAST NP AATmosphere Program
Support for Alphas and families from the ARALAST NP AATmosphere program.
Easy Start Sample Program
Baxter is offering Alpha-1 patients (who have not previously used ARALAST NP therapy) and their physicians the opportunity to receive up to a two-week sample supply for a no-charge trial.
To initiate the process to receive a complimentary two-week trial sample of ARALAST NP therapy, please call 1-866-ARALAST (272-5278).
You can have confidence in Baxter's...
- Commitment to a reliable supply of ARALAST NP therapy
- Distribution of ARALAST NP therapy through Specialized Pharmacy Providers who provide comprehensive in-home care
- Support for the Alpha-1 community through continued AAT deficiency research
- Patient Assistance programs, including Baxter's Alpha-1 Security Program
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
